Top Stories
The Swiss startup aims to restore autonomy for people living with severe neurological conditions, including ALS, spinal cord injury and stroke.
CEO Jason Haider said the platform provides range-of-motion assessments "without the need for reflective markers or wearable sensors."
The deal will give Tempus control of a whole-genome blood test already covered by Medicare in three indications, after two years of co-commercialising it with Personalis.
Company says new 'powerful AI factory' will improve decision-making from discovery through clinical development.
The surgical robotics company will hold a special meeting Tuesday for shareholders to vote on a proposal to liquidate its assets.
Conference News
CMR Surgical will demonstrate at SRS 2026, for the first time to a surgical audience, the potential for Versius Plus™ to leverage surgical data to help predict how a procedure may unfold.Built on NVID...
Research focused on oncology, immunology, psychiatry, Crohn’s disease and MorePALO ALTO, Calif.--(BUSINESS WIRE)-- Atropos Health, the world’s largest creator of real-world evidence (RWE) for clinical...
Jul 22, 2026, 09:00 ETSupporting ADLM's focus on collaborative, cross-disciplinary solutions that address laboratory workforce and operational challengesHighlighting innovations in mass spectrometry, ...
New system preserves simplicity and existing workflows and is designed to enable future innovation, including high-plex panel testing, fast time-to-result, and new sample-to-answer solutions.SUNNYVALE...
As a Premier Partner, Gene Solutions presented Asia-led real-world evidence from large-scale NIPT-integrated carrier screening, alongside advances in AI-enabled pregnancy-risk assessment and minimally...
